$7.27 -0.37 (-4.84%)
11/6/2009 4:00 PM

NeurogesX, Inc. (NGSX)

CAPS Rating: 2 out of 5

A biopharmaceutical company, which focused on developing and commercializing novel pain management therapies.

Current Price $7.27 Mkt Cap $128.04M
Open $7.60 P/E Ratio 0.24
Prev. Close $7.64 Div. (Yield) N/A (N/A)
Daily Range $7.20 - $7.65 Volume 49,602
52-Wk Range $0.89 - $9.20 Avg. Daily Vol. 35,000

Related News and Articles

Caps

How do you think NGSX will perform vs the S&P 500?

Add Stock to Watchlist

All Members

21 Outperform
5 Underperform
 

All-Star Members

7 Outperform
0 Underperform
 

Wall Street

4 Outperform
0 Underperform
 

Top NGSX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

pennysplants (99.37)
Submitted September 05, 2007

NGSX has been on my watch list for ages, but was under the 100m market cap. So, I had to sit on my hands.

With phase 3 trial "results" announced yesterday, it's now "pickable". [And no, I don't hate myself in the mirror… More

1 Comment | Reply | Report this Post

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NGSX VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about NGSX.

Recs

1
Member Avatar pennysplants (99.37) Submitted: 9/5/2007 5:55:00 PM : Outperform Start Price: $7.76 NGSX Score: +17.41

NGSX has been on my watch list for ages, but was under the 100m market cap. So, I had to sit on my hands.

With phase 3 trial "results" announced yesterday, it's now "pickable". [And no, I don't hate myself in the mirror today. It's the 24 hour delay thing. I would have rather bought yesterday].

Pain patch. Chili peppers (don't laugh -- I'm a believer). Sufficient cash on hand to commercialize... or at least get er go'n.

AND, the head honcho made "the street.com" look like monkeys. I know that may not be hard to do ... but it's done so infrequently ... as to merit some notice.

Anyway, NGSX is for the speculative small cap portion of my portfolio. Hope it doesn't get bought out too soon.

Report this Post 1 Comment | Reply | Permalink
View All 1 Pitches »

Leaderboard

Find the members with the highest scoring picks in NGSX.

Score Leader

TrackRothCapital

TrackRothCapital (75.81) Score: +115.20

The Score Leader is the member with the highest score across all their picks in NGSX.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
chachomcd 29.68 2/28/2008 Outperform 3M $4.22 +72.27% -18.47% +90.75
fred0053 98.25 2/28/2008 Outperform 3W $4.26 +70.70% -18.88% +89.58
pennysplants 99.37 9/5/2007 9/23/2009 Outperform 1Y $7.76 -6.31% -23.72% +17.41 2 Comments
series7scott 20.07 6/22/2007 Outperform 1Y $8.33 -12.73% -25.57% +12.85
littlecramer 68.39 7/5/2007 Outperform NS $8.51 -14.57% -26.00% +11.43
anticitrademix < 20 11/2/2009 Underperform 5Y $7.94 -8.44% +2.88% +11.32
anticitrademix2 < 20 11/2/2009 Underperform 5Y $7.94 -8.44% +2.88% +11.32
BigHiegs 91.47 6/21/2007 Outperform 3M $8.48 -14.27% -25.36% +11.09
pituach 64.55 10/31/2007 Outperform NS $8.67 -16.19% -27.08% +10.90
jazzkeys 98.80 10/1/2007 Outperform 5Y $8.70 -16.44% -26.87% +10.43
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackZacks 69.52 6/10/2009 Outperform 3M $6.18 +17.64% +14.68% +2.96 1 Comment
TrackRothCapital 75.81 2/28/2008 Outperform NS $3.70 +96.49% -18.72% +115.20
TrackPacificGrow 90.86 6/12/2007 Outperform NS $8.98 -19.04% -24.69% +5.65
TrackLazardCapit < 20 6/11/2007 Outperform NS $7.96 -8.67% -24.93% +16.26

Featured Broker Partners